Some studies have explored the effect of anti-hypertensive, anti-diabetes, and statin drugs on Alzheimer’s disease and found that they may lead to a relative reduction in SPP1 levels [44–48]. The gene discussed is SPP1; the disease is early-onset autosomal dominant Alzheimer disease.